Cargando…
HER2 decreases drug sensitivity of ovarian cancer cells via inducing stem cell-like property in an NFκB-dependent way
Increasing evidence shows that cancer stem cells are responsible for drug resistance and relapse of tumors. In breast cancer, human epidermal growth factor receptor 2 (HER2) induces Herceptin resistance by inducing cancer stem cells. In the present study, we explored the effect of HER2 on cancer ste...
Autores principales: | Wang, Wenxiang, Gao, Yuxia, Hai, Jing, Yang, Jing, Duan, Shufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422889/ https://www.ncbi.nlm.nih.gov/pubmed/30314995 http://dx.doi.org/10.1042/BSR20180829 |
Ejemplares similares
-
Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB
por: Ou, Chien-Chih, et al.
Publicado: (2012) -
NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL
por: Aydin, Cigdem, et al.
Publicado: (2010) -
12-HETE facilitates cell survival by activating the integrin-linked kinase/NF-κB pathway in ovarian cancer
por: Liu, Qian, et al.
Publicado: (2018) -
MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
por: Du, Cheng, et al.
Publicado: (2014) -
Toll-Like Receptor 4 Inhibits Estradiol Secretion via NF-κB Signaling in Human Granulosa Cells
por: Guan, Hai-Yun, et al.
Publicado: (2021)